Key Metrics

CiteScore

2.1

H-Index

SNIP

0.62

Recommended pre-submission checks

Topics Covered on Atherosclerosis Supplements

Atherosclerosis Supplements Journal Specifications

Indexed in the following public directories

CrossRef
Scopus
Web of Science

Overview
Publisher	ELSEVIER IRELAND LTD
Language	English
Frequency	Bi-monthly
General Details
Language	English
Frequency	Bi-monthly
Publication Start Year	2000
Publisher URL	Visit website

View less

Planning to publish in Atherosclerosis Supplements ?

Upload your Manuscript to get

Degree of match
Common matching concepts
Additional journal recommendations

Check your researchless than 30 sec

FAQs on Atherosclerosis Supplements

How long has Atherosclerosis Supplements been actively publishing?

What is the publishing frequency of Atherosclerosis Supplements?

What is the eISSN & pISSN for Atherosclerosis Supplements?

What is Citescore for Atherosclerosis Supplements?

What is the H Index for Atherosclerosis Supplements ?

What is SNIP score for Atherosclerosis Supplements?

Who is the publisher of Atherosclerosis Supplements?

Global Journal Library:

Q: How long has Atherosclerosis Supplements been actively publishing?

Atherosclerosis Supplements has been in operation since 2000 till date.

Q: What is the publishing frequency of Atherosclerosis Supplements?

Atherosclerosis Supplements published with a Bi-monthly frequency.

Q: What is the eISSN & pISSN for Atherosclerosis Supplements?

For Atherosclerosis Supplements, eISSN is 1878-5050 and pISSN is 1567-5688.

Q: What is Citescore for Atherosclerosis Supplements?

Citescore for Atherosclerosis Supplements is 2.1.

Q: What is the H Index for Atherosclerosis Supplements ?

H Index for Atherosclerosis Supplements is 46.

Q: What is SNIP score for Atherosclerosis Supplements?

SNIP score for Atherosclerosis Supplements is 0.62.

Q: Who is the publisher of Atherosclerosis Supplements?

ELSEVIER IRELAND LTD is the publisher of Atherosclerosis Supplements.

Atherosclerosis Supplements : Impact Factor & More